[1]
“TREATMENT-RESISTANT DEPRESSION: KETAMINE, ESKETAMINE, AND EMERGING NEUROSTIMULATION MODALITIES ”, CUSR, vol. 4, no. 8, pp. 17–19, Sep. 2026, doi: 10.66301/v8ekf719.